US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 10.380
  • -2.700-20.64%
Close Jul 24 16:00 ET
  • 10.625
  • +0.245+2.36%
Post 16:56 ET
624.69MMarket Cap-1237P/E (TTM)

Sage Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sage Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Jul 31, 2024

Revenue(YoY)

8.91M

+260.01%
EPS(YoY)

-1.64

+38.94%
Analyst Rating

Hold

Jul 24, 2024

Sage Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.843M--
Jul 31, 20242024/Q2-- / 8.907M--
Apr 25, 20242024/Q17.902M / 5.187M--
Feb 14, 20242023/Q477.972M / 60.976M--
Nov 7, 20232023/Q32.716M / 3.173M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.843M--
Jul 31, 20242024/Q2-- / 8.907M--
Apr 25, 20242024/Q17.902M / 5.187M--
Feb 14, 20242023/Q477.972M / 60.976M--
Nov 7, 20232023/Q32.716M / 3.173M--

Unlock Free Earnings Estimates

Sage Therapeutics Earnings Reports

  • Sage Therapeutics | 10-Q: Quarterly report

    Apr 25 07:20 ET

  • Sage Therapeutics | 10-K: Annual report

    Feb 14 07:22 ET

  • Sage Therapeutics: Q3 2023 Earnings Report

    Nov 7, 2023 07:00 ET

  • Sage Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 7, 2023 07:20 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 24, 2024

    Hold

    • Buy

      23.08%

    • Hold

      61.54%

    • Sell

      15.39%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg